Long-term fluvastatin reduces the hazardous effect of renal impairment on four-year atherosclerotic outcomes (a LIPS substudy).
13 auth.
P. Lemos,
P. Serruys,
P. D. de Feyter,
N. Mercado,
Dick M. Goedhart,
F. Saia,
C. Arampatzis,
P. Soares,
M. Ciccone,
M. Arquati,
...
M. Cortellaro,
W. Rutsch,
V. Legrand
|
|
5 |
2005 |
Social Media Posts